Erlander Mark has filed 3 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 758400 shares of Cardiff Oncology, Inc. ($CRDF) on March 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2025 | Cardiff Oncology, Inc. | $CRDF | Erlander Mark | Chief Executive Officer | A | Stock Options | 758400 | $0.00 | 2,925,098.0000 | 66,524,294 | 35.00% | 1.14% |
| March 7, 2024 | Cardiff Oncology, Inc. | $CRDF | Erlander Mark | Chief Executive Officer | A | Stock Options | 510000 | $0.00 | 2,170,310.0000 | 0 | 30.72% | 0.00% |
| March 15, 2023 | Cardiff Oncology, Inc. | $CRDF | Erlander Mark | Chief Executive Officer | A | Stock Options | 482064 | $0.00 | 1,664,477.0000 | 0 | 40.77% | 0.00% |